COMPANY
Serinus Biosciences
NIH awards 1
- NIH award 1R44GM165171-01 FY2026: $349,090 awarded for that fiscal year; activity R44 (SBIR); PI SHERMAN, MAXWELL AARON; recipient as written: SERINUS BIOSCIENCES INC, NEW YORK, NY. A massively parallel cell-based pl source ↗
Funding and NIH signals
- NIH award NIH awarded $349K (SBIR Phase II 1R44GM165171-01, new, notice Sep 17, 2026). NIH RePORTER 1R44GM165171-01 (Sep 17, 2026)
Evidence (1 event)
- Sep 17, 2026 · NIH RePORTER 1R44GM165171-01
Organization: SERINUS BIOSCIENCES INC; City/State: NEW YORK, NY; Project number: 1R44GM165171-01; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-09-17; FY total cost (award amount): 349090; Administering IC: National Institute of General Medical Sciences; Project title: A massively parallel cell-based platform for the rational discovery of molecular glues; Organization type: Domestic For-Profits
- Sep 17, 2026 · NIH RePORTER 1R44GM165171-01